These are MY thoughts. Almost always, there is MORE money to be made as a distributor and/or dealer than as a manufacturer. Our patent rights are golden (ask Rambus), but our ability to partner with a large already established distribution agency OR to simply sell them the rights to our technology for cash, commissions, etc. are paramount, I believe, to our greater success….speaking about the RETAIL, NON government aspect of the business. Ed has mentioned before in press releases and shareholder communications that MZEI “intends to hang on to” the government bio-terrorism unit. As I see it, government interest in MZEI would likely be a more top secret project - not unlike development of various military projects over the years. While we could still operate that aspect of the business as a public company, we would not need distributors, dealers, etc., to “handle” that aspect of the unit sales for us. Therefore, I can envision a business idea that we would sell or lease AsepticSure to a multi-national company for cash, perhaps further stock options in THAT company, while at the same time keeping the government variant “in house.” Frankly, this scenario makes the most sense to me. Already, AMI reported what might be a “perceived market value” for AsepticSure at this juncture. I would not be surprised if behind the scenes negotiations are not already taking place pertaining to this with one or more large companies interested in AsepticSure. At what price per share would it take to make a deal? That’s anyone’s guess at this point. I’d THINK it would likely be $10.00 cash per share or higher, maybe with stock options of some kind thrown in as well. I DON’T think we are far from this scenario NOW. Then, MZEI, the government contractor, would be free to concentrate on THAT side of the business. I DON’T think MZEI as a company would be sold, only the technology for use in non-government arenas. Once we get past all of this, I see a scenario which would lead us back into the lab to refresh and fine tune our blood purification variant, which was our original goal dating back 2 decades. IMO.
